September 10, 2011 - Volume 25 - Issue 14
pp: 1683-1805

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.


Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

Pacheco, Yovana; Solé, Véronique; Billaud, Eric; More

AIDS . 25(14):1701-1710, September 10, 2011.

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.


Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.


Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Concise Communication